Kolexia
Flament-Batt Caroline Santé publique
Flament-Batt Caroline
Santé publique
Clinique Victor Pauchet De Butler
Amiens, France
27 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Mélanome Tumeurs cutanées COVID-19 Tumeurs stromales gastro-intestinales Carcinomes Dysbiose Tumeurs du péritoine Tumeurs de l'ovaire Tumeurs du côlon

Collaborateurs

Voir plus
Zitvogel Laurence
Zitvogel Laurence
Gustave-Roussy, Villejuif, France
Chaput-Gras Nathalie
Chaput-Gras Nathalie
Gustave-Roussy, Villejuif, France
Soria Jean-Charles
Soria Jean-Charles
Gustave-Roussy, Villejuif, France
Robert Caroline
Robert Caroline
Gustave-Roussy, Villejuif, France

Industries

Voir plus
{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies.
Oncoimmunology   04 janvier 2023
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.
Cancer discovery   06 octobre 2022
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals.
Cancer discovery   05 avril 2022
Bacteria-specific CXCL13-producing follicular helper T cells are putative prognostic markers to neoadjuvant PD-1 blockade in muscle-invasive urothelial carcinoma.
2022 ASCO Genitourinary Cancers Symposium   16 février 2022
Phase I clinical trial combining imatinib mesylate and IL-2: HLA-DR NK cell levels correlate with disease outcome.
Oncoimmunology   21 octobre 2021
Phase I clinical trial combining imatinib mesylate and IL-2 in refractory cancer patients: IL-2 interferes with the pharmacokinetics of imatinib mesylate.
Oncoimmunology   21 octobre 2021
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.
Cell death and differentiation   06 juillet 2021
Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer.
Nature medicine   25 mai 2020
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.
Science (New York, N.Y.)   02 novembre 2017
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.
Immunity   04 octobre 2016